Chemed Corporation cash flow to debt ratio of 250.89% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Chemed Corporation's free cash flow has decreased 11.55% from $367.97M last year to $325.48M, signaling decreasing performance

Chemed Corporation's debt to equity ratio is 0.36, which means that the company's assets are healthy financed, signaling financial stability.

Chemed Corporation's debt has increased relative to shareholder equity from 0.13 last year to 0.36 today, signaling weakened financials

Chemed Corporation has a net debt to EBITDA ratio of 0.19x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Chemed Corporation earns at least as much interest as it pays. Interest obligations are fully covered.

Chemed Corporation's profit margin has decreased (14.69%) in the last year from 12.42% to 10.60%, signaling decreasing performance

Chemed Corporation's short-term assets of $302.62M exceed its short-term liabilities of $287.13M

Chemed Corporation's return on assets of 17.41% is higher than the 5.00% threshold, indicating efficient asset utilization

Chemed Corporation's return on equity of 29.45%, is higher than 15.00%, indicating good performance

Chemed Corporation's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Chemed Corporation had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Chemed Corporation has positive free cash flow, indicating the company generates cash after capital expenditures

Chemed Corporation has a free cash flow yield of 4.53%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Chemed Corporation's yearly earnings has decreased 12.17% since last year from $302.00M to $265.24M, signaling decreasing performance

Chemed Corporation's yearly revenue has increased 4.06% since last year from $2.43B to $2.53B, signaling increasing performance

ROIC 19.99% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Chemed Corporation's 3-year revenue CAGR of 5.82% is positive, indicating growing revenue over the past 3 years

Chemed Corporation had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Chemed Corporation had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Chemed Corporation is overvalued relative to its fair value price of 212.55 based on Discounted Cash Flow model

Chemed Corporation has an earnings yield of 3.73%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Chemed Corporation is overvalued relative to its fair value price of 208.96 based on EBITDA multiple model

Chemed Corporation has an EV/EBITDA ratio of 17.19x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Chemed Corporation is overvalued relative to its fair value price of 332.82 based on Earnings Fair Value model

Chemed Corporation's earnings growth over the measurement period is negative; the PEG ratio is not meaningful and the check fails.

Chemed Corporation has a price-to-book ratio of 8.88x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Chemed Corporation has a price-to-sales ratio of 2.84x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue